Global Cancer Biomarkers Market Set for Rapid Growth, to Reach Value Around $26,000 Mn by 2024
Global cancer biomarkers market expected to generate revenue of around USD 26,000 million by end of 2024, growing at a CAGR of around 13% between 2018 and 2024. Cancer biomarkers are perceptible substances, that are used as an indicator of the biological status of the tumor and hence they are used to analyze the prognostic and diagnostic stages of cancer.
View full press release